NCT07399158 2026-02-10
CROSSROAD: Treatment Regimen Switch - Re-induction Chemotherapy vs. Direct Radiotherapy in LANPC With Inadequate Response to Induction Chemotherapy
Fujian Cancer Hospital
Not yet recruiting
Clinical Trials
20 trialsNCT07331428 2026-01-09
MRG003 Induction and Capecitabine Maintenance With PD-1 in Locally Recurrent NPC
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT07252375 2025-11-26
A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal Carcinoma
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT06775756 2025-01-15
Reducing Dose and Irradiated Volume in Cervical Prophylactic Irradiation for Nasopharyngeal Cancer
Fujian Cancer Hospital
Phase 3 Not yet recruiting
NCT06572293 2024-10-16
Effect of Nurse-Led Individualized Follow-Up Intervention on Patients With Nasopharyngeal Carcinoma
Fujian Cancer Hospital
Phase NA Not yet recruiting
NCT05099978 2024-09-04
A-TRAIN
National Cancer Center, Japan
Unknown
NCT06136962 2023-11-18
Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life
Fujian Cancer Hospital
Unknown
NCT06095167 2023-10-23
Induction Chemotherapy and Immunotherapy Combined Radiotherapy With or Without Concurrent Chemotherapy for Stage III-IVa NPC
Fujian Cancer Hospital
Phase 3 Not yet recruiting
NCT05519956 2022-09-19
Elective Level Ib Irradiation in Nasopharyngeal Carcinoma Patients Based on the International Guidelines
Fujian Cancer Hospital
Phase 3 Unknown
NCT04955886 2021-07-09
Surufatinib Combined With Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma
Fujian Cancer Hospital
Phase 2 Unknown
NCT04387266 2020-10-09
To Evaluate the Efficacy and Feasibility of Modified Reduce-volume Target IMRT in the Treatment of Patients With Non-metastatic NPC
Fujian Cancer Hospital
Completed
NCT03648697 2020-08-11
EBV-TCR-T（YT-E001）for Patients With EBV-positive Recurrent or Metastatic NPC
Fujian Cancer Hospital
Phase 2 Unknown
NCT04421469 2020-06-09
Triprilimab(JS001) and Chemotherapy Combined With Local Treatment for Multiple Metastatic NPC
Fujian Cancer Hospital
Phase 2 Unknown
NCT04319471 2020-03-24
Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma
Fujian Cancer Hospital
Phase 2 Unknown
NCT04220528 2020-01-07
Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC
Fujian Cancer Hospital
Phase 2 Unknown
NCT03666221 2018-09-11
Nimotuzumab for Recurrent Nasopharyngeal Carcinoma
Fujian Cancer Hospital
Phase 2 Unknown
NCT00697905 2014-11-21
Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma
Ministry of Health, Malaysia
Phase 2 Completed
NCT01086488 2011-07-08
FOSCAN
Ministry of Health, Malaysia
Phase 2 Unknown
NCT00563862 2011-06-16
Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0)
Hospital Authority, Hong Kong
Phase NA Terminated
NCT00563927 2010-07-07
Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)
Hospital Authority, Hong Kong
Phase NA Unknown